Fernandez-Guzman Daniel, Caira-Chuquineyra Brenda, Baca-Rondan Fiorella, Yucra-Sosa Maria Cristina, Ccami-Bernal Fabricio, Soriano-Moreno David R, Nieto-Gutierrez Wendy, Benites-Zapata Vicente A
Universidad Cientifica del Sur, Lima, Peru.
Facultad de Medicina, Universidad Nacional de San Agustín de Arequipa, Arequipa, Peru.
Heliyon. 2023 Apr;9(4):e15366. doi: 10.1016/j.heliyon.2023.e15366. Epub 2023 Apr 8.
To evaluate the association between self-rated evidence-based medicine (EBM) competencies and the prescription of drugs without scientific evidence against mild COVID-19 (present with any of the signs and symptoms of COVID-19 but who do not have shortness of breath, dyspnea, or abnormal chest imaging) among recently graduated physicians in Peru.
We conducted an analytical cross-sectional study where we evaluated a non-probability sample of recently graduated physicians during June and July 2021 (end of second wave of COVID-19 in Peru). Self-rated EBM competencies were assessed by four domains (formulation of a clinical question, search, analysis, and application) using a Likert scale with scores from zero to four ("Very inadequate" = 0, to "Very Adequate" = 4), it was considered as "Adequate" if the score was three or four. In addition, the variable "General competence on EBM" was rated as "Adequate" if in all domains evaluated it presented an adequate self-rating. For the outcome, drug prescription, we considered the use of ivermectin, azithromycin, other antibiotics, hydroxychloroquine, dexamethasone, and anticoagulants (drugs with no efficacy demonstrated for patients with mild COVID-19). To assess the association, we used Poisson regression models with robust variances and obtaining crude (cPR) and adjusted (aPR) prevalence ratios with their 95% confidence intervals (95%CI).
Of a total of 239 physicians included 70.7% prescribed at least one drug without scientific evidence. A total of 51.1% reported adequate ratings in all evaluated domains of EBM. Self-rating the "Clinical Question Formulation" competency as adequate was associated with a lower frequency of prescribing medications for mild COVID-19 (aPR: 0.93; 95% CI: 0.91-0.95). While self-rating as adequate the competency of "Identify possible implications of investigations" was associated with an increase in the prescription of such drugs (aPR: 1.14; 95% CI: 1.09-1.20). Additionally, self-rating all domains as adequate were associated with less prescription (aPR: 0.93; 95% CI: 0.90-0.96).
Seven out of ten recently graduated physicians prescribed some type of medication without scientific evidence to treat patients with mild COVID-19. Having adequate self-perceived EBM competencies was associated with a lower frequency of prescribing medications without scientific evidence to manage patients with mild COVID-19.
评估秘鲁近期毕业的医生自我评定的循证医学(EBM)能力与针对轻度新型冠状病毒肺炎(COVID-19)患者(表现出COVID-19的任何体征和症状,但无呼吸急促、呼吸困难或胸部影像学异常)开具无科学依据药物处方之间的关联。
我们开展了一项分析性横断面研究,在2021年6月和7月(秘鲁第二波COVID-19疫情结束时)对近期毕业医生的非概率样本进行评估。使用李克特量表从四个领域(临床问题的提出、检索、分析和应用)评估自我评定的EBM能力,分数从0到4(“非常不足”=0,到“非常充足”=4),如果分数为3或4,则认为是“充足”。此外,如果在所有评估领域的自我评定都为充足,则将“EBM总体能力”变量评定为“充足”。对于结果变量药物处方,我们考虑使用伊维菌素、阿奇霉素、其他抗生素、羟氯喹、地塞米松和抗凝剂(对轻度COVID-19患者无疗效证明的药物)。为评估这种关联,我们使用了具有稳健方差的泊松回归模型,并获得粗患病率比(cPR)和调整患病率比(aPR)及其95%置信区间(95%CI)。
在纳入的239名医生中,70.7%开具了至少一种无科学依据的药物。共有51.1%的医生报告其在EBM所有评估领域的评定为充足。将“临床问题提出”能力自我评定为充足与轻度COVID-19患者药物处方频率较低相关(aPR:0.93;95%CI:0.91-0.95)。而将“识别检查可能的影响”能力自我评定为充足与此类药物处方增加相关(aPR:1.14;95%CI:1.09-1.20)。此外,将所有领域自我评定为充足与较少的处方相关(aPR:0.93;95%CI:0.90-0.96)。
十分之七的近期毕业医生开具了某种无科学依据的药物来治疗轻度COVID-19患者。自我感知具有充足的EBM能力与针对轻度COVID-19患者开具无科学依据药物的频率较低相关。